Dr. Marydee Anerousis

D.D.S. | Dentist



  
  283 S Orange Ave, Livingston
  New Jersey, 07039-5901

  973-535-8539    Maps & Directions
Dr. Marydee Anerousis is a Livingston, New Jersey based Dentist who is specialized in General Practice Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 283 S Orange Ave, Livingston. Patients can reach her at 973-535-8539.
Dr. Marydee Anerousis is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Marydee Anerousis speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Marydee Anerousis
Specialization: Dentist
Gender:Female
Credentials: D.D.S.
Accepts Medicare Assignment:May Accept
Practice Address:283 S Orange Ave, Livingston,
New Jersey, 07039-5901
Phone:973-535-8539
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0244538999
Enrollment ID: I20160412002598
NPI Number: 1871675769
NPI Enumeration Date: 19 Oct, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 283 S Orange Ave,
Livingston, New Jersey
Zip: 07039-5901
Phone Number: 973-535-8539
Patients can reach Dr. Marydee Anerousis at 283 S Orange Ave, Livingston, New Jersey or can call to book an appointment on 973-535-8539. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.

Comments/ Reviews: